standard]
MGLPYVVCLCAAVFLLHSSLFPVSAKKTYIVQMNHQQKPPSYATHGQWYS
DHLQTLTSAAPESILYTYGSAYNGFAAALSDEEVESLRQSDSVLDVYEDP
VYTLHTTRTPEFLGLDTELAPSVGHSLQELNQASQEVIIGVLDTGVWPES
KSFSDKDMADVPARWQGECEAADDFDPKIHCNKKLIGARFFSRGYNMASG
SNESESPRDSDGHGTHTASTAAGAQVENASLLGYASGNARGMATHARLAT
YRVCWKSGCLGSDILAAMDRAIQDGVDVLSLSLGGGSAPYARDPIAVGAY
GGPAKSSLANVAPWIMTVGAGTIDRDFPAFATLGNGQKYAGVSLYSGAGM
GSRSVELVYNQGGNSSSNLCLAGSLDPAIVRGKVVLCDRGISARVEKGAV
VRDAGGVGMILANTAASGEELVADSHLLPAVAVGRKVGDMIRQYVKTTQN
PTAVLSFGGTVVNVKPSPVVAAFSSRGPNTVTPQILKPDVIGPGVNILAA
WSQDVGPTGLEKDTRKTQFNIMSGTSMSCPHISGLAALLKAAHPEWSPSA
IKSALMTTAYTLDNTNSPLKDAADYSISTPWAHGAGHVDPQKALSPGLVY
DAKPEDYIAFLCSLDYTMEMIQAIVKHPNVTCAAKFRDPGQLNYPSFSVV
FGKSRVVRYTRRLTNVGAAGSVYRVSVEAPPNVVVSVKPSNLVFRNVGDR
QRYTVTFVSQKGVDPLHNGFGSITWKNEQHQVRSPVAFSWSRQ
|
IPR000209; Peptidase S8/S53, subtilisin/kexin/sedolisin IPR003137; Protease-associated domain, PA IPR010259; Proteinase inhibitor I9, subtilisin propeptide IPR022398; Peptidase S8/S53, subtilisin, act |